Join to view full profile
1500 Duarte RdDuarte, CA 91010
Phone+1 626-256-4673
Fax+1 626-218-8233
Dr. Dorff is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Tanya Dorff, MD is an oncologist based in Duarte, CA, specializing in genitourinary and hematologic oncology. She completed her education and fellowships in Hematology and Medical Oncology at the University of Southern California/LAC+USC Medical Center and her residency in Internal Medicine at the Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital. Currently, she is an associate professor at City of Hope's Helford Clinical Research Hospital and experienced in handling various urologic conditions including testicular neoplasms, prostate cancer, and bladder cancer. Dr. Dorff has contributed to several publications and has been a part of clinical trials related to prostate and bladder cancer treatments. In 2013, she received the "Top Doctors: LA Area" award from Castle Connolly.
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2005 - 2006- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2004 - 2005
- University of Southern California/LAC+USC Medical CenterFellowship, Medical Oncology, 2003 - 2004
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2000 - 2003
David Geffen School of Medicine at UCLAClass of 2000
Certifications & Licensure
CA State Medical License 2003 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2015, 2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2015, 2017
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and Cerner Patient Portal, Cerner Corporation, 2015, 2017
Clinical Trials
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
- Short-Term Fasting: Impact on Toxicity Start of enrollment: 2009 Jul 09
- Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Publications & Presentations
PubMed
- Correction: Navigating drug-drug interactions with apalutamide.Bilal A Siddiqui, Karine Tawagi, Sarah Caulfield, Pankaj Aggarwal, Tanya Dorff
Prostate Cancer and Prostatic Diseases. 2026-09-01 - Navigating drug-drug interactions with apalutamide.Bilal A Siddiqui, Karine Tawagi, Sarah Caulfield, Pankaj Aggarwal, Tanya Dorff
Prostate Cancer and Prostatic Diseases. 2026-09-01 - Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer.Susan F Slovin, Xin Gao, Xiao X Wei, David Y Oh, Rana R McKay
Clinical Cancer Research. 2026-08-14
Lectures
- Closing the Gap: Knowledge Gaps and Interpreting Current Data in the Era of Novel Imaging — Medical...ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- A randomized phase II clinical trial of a fasting-mimic diet prior to chemotherapy to evaluate the impact on toxicity and efficacy.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Radium‑223 Plus Enzalutamide Boosts Survival in Metastatic Prostate CancerMarch 3rd, 2026- “Big, Important Studies”: What Experts Say to Watch for at ASCO GU 2026February 23rd, 2026
- Biden’s Diagnosis Renews Focus on Prostate Cancer RisksMay 19th, 2025
Grant Support
- Intermittent Fasting using a Fasting-Mimetic Diet to Improve Prostate Cancer Control and Metabolic OutcomesCEDARS-SINAI MEDICAL CENTER2023–2028
- Integrated Genotypic, Phenotypic and Immunologic Analysis of Ethnically Diverse Prostate CancersBECKMAN RESEARCH INSTITUTE/CITY OF HOPE2022–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
